Recursion Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discov…

Biotechnology
US, Salt Lake City [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Recursion Pharmaceuticals, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of RXRX's Analysis
CIK: 1601830 CUSIP: 75629V104 ISIN: US75629V1044 LEI: - UEI: -
Secondary Listings
RXRX has no secondary listings inside our databases.